Company page
Tanvex Biopharma, Inc.
Tanvex Biopharma, Inc. is a publicly traded company on the Taiwan stock market under the ticker 6541. The company has a market capitalization of approximately 321.63 million USD. Tanvex focuses on biopharmaceutical development and aims to advance innovative therapies.
- Ticker
- 6541:TWSE
- Asset type
- Stock
- Market cap
- $321.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD